Načítá se...
Relaxin-2 in Cardiometabolic Diseases: Mechanisms of Action and Future Perspectives
Despite the great effort of the medical community during the last decades, cardiovascular diseases remain the leading cause of death worldwide, increasing their prevalence every year mainly due to our new way of life. In the last years, the study of new hormones implicated in the regulation of energ...
Uloženo v:
| Vydáno v: | Front Physiol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5563388/ https://ncbi.nlm.nih.gov/pubmed/28868039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphys.2017.00599 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|